Hyasen Biotechnology Participates Successfully in Genética 2026

Hyasen Biotechnology concluded a successful participation in the Genética 2026 congress, held in Florianópolis, Brazil, from September 29 to October 2. Hyasen Biotechnology's presence at the congress was marked by its active engagement with attendees at Booth 10, walking visitors through the company’s portfolio of molecular biology solutions spanning the full workflow from sample preparation to genomic analysis.

The company showcased its comprehensive range of products, including:

- Nucleic Acid Extraction & Purification: featuring Proteinase K, DNase I, magnetic microspheres, and related reagents for efficient DNA/RNA recovery. - PCR & RT-PCR Solutions: high-performance polymerases, reverse transcriptases, and premixes. - qPCR & RT-qPCR Solutions: real-time PCR reagents built for sensitivity and workflow flexibility. - LAMP & RT-LAMP Solutions: isothermal amplification enzymes and master mixes. - NGS Solutions: library preparation reagents for DNA and RNA sequencing workflows. - Molecular Biology Enzymes & Reagents: core enzymes supporting diagnostics, genomic research, and industrial applications.

The booth conversations covered a wide range of topics, from technical questions about specific enzyme performance and protocol compatibility to broader discussions about distribution and OEM/ODM partnership opportunities for companies looking to integrate Hyasen Biotechnology's manufacturing capabilities into their regional product lines. The diversity of the congress participants was evident, with a strong cross-section of Brazil's research community in attendance. This included human genetics, animal genetics, plant genetics, microbial genetics, bioinformatics, and biotechnology. The variety of visitors, from academic researchers to diagnostic manufacturers, underscored the broad appeal and relevance of the event.

Hyasen Biotechnology expressed gratitude to all attendees and the congress organizers for a well-run event. The company remains committed to continuing the conversations initiated at the congress, offering support for product applications, technical requirements, and potential collaborations.

The congress offered Hyasen Biotechnology a valuable opportunity to connect face-to-face with the scientists and institutions driving genetics research forward in Latin America. Throughout the event, the company engaged with attendees, providing detailed information about its product offerings and exploring potential collaboration opportunities. The company's comprehensive portfolio of molecular biology solutions, including Nucleic Acid Extraction & Purification, PCR & RT-PCR Solutions, qPCR & RT-qPCR Solutions, LAMP & RT-LAMP Solutions, NGS Solutions, and Molecular Biology Enzymes & Reagents, was well-received by the diverse audience.

The event concluded on October 2, with Hyasen Biotechnology looking forward to continuing its engagement with the genetics and genomics community in Brazil and beyond. The company's commitment to supporting research and development in the field was evident throughout the congress, and the positive interactions at Booth 10 reinforced Hyasen Biotechnology's position as a key player in the molecular biology solutions market.